Drug intelligence / Profile preview

transferrin receptor antibody

Development stage
Preclinical
Lead developer
University of Iowa
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Transferrin receptor antibody refers to a class of monoclonal antibodies designed to target the transferrin receptor (TfR), also known as CD71. TfR is highly expressed on the surface of rapidly proliferating cells, including many types of cancer cells, as well as on the blood-brain barrier (BBB) endothelium. In the context of oncology, such as multiple myeloma, these antibodies function by blocking the interaction between TfR and iron-carrying transferrin, thereby depriving tumor cells of essential iron and inhibiting their growth and survival. Additionally, TfR antibodies are extensively utilized as molecular shuttles to facilitate the transport of therapeutic payloads across the blood-brain barrier into the central nervous system.

Other names
anti-TfR antibodyanti-CD71 antibodyanti-CD-71 antibodyanti-CD 71 antibodytransferrin receptor 1 antibody
02

Targets

TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on transferrin receptor antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on transferrin receptor antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call